Role of apolipoprotein e (apoe) polymorphism on left cardiac failure in homozygous β thalassaemic patients

@article{Ferrara2001RoleOA,
  title={Role of apolipoprotein e (apoe) polymorphism on left cardiac failure in homozygous β thalassaemic patients},
  author={M. Ferrara and S. M. Matarese and M. Francese and B. Borrelli and L. Coppola and A. Coppola and D. Iarussi and L. Esposito},
  journal={British Journal of Haematology},
  year={2001},
  volume={114}
}
  • M. Ferrara, S. M. Matarese, +5 authors L. Esposito
  • Published 2001
  • Medicine
  • British Journal of Haematology
    • View on Wiley
    onlinelibrary.wiley.com
    16 Citations
    Highly Influential Citations
    1
    Background Citations
    11
    Results Citations
    1

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

    16 Citations
    Citation Type

    Citation Type

    Apolipoprotein E gene polymorphism and the risk of left ventricular dysfunction among Egyptian β-thalassemia major.
    • 7
    • Highly Influenced
    Association of GSTT1/GSTM1 and ApoE variants with left ventricular diastolic dysfunction in thalassaemia major patients
    • 6
    Apolipoprotein E Polymorphism and Left Ventricular Failure in Beta‐Thalassemia: A Multivariate Meta‐Analysis
    • 4
    Usefulness of Pulsed Wave Tissue Doppler Imaging in Assessment of Left Ventricular Functions in Children with Beta-Thalassemia Major
    • 11
    • PDF
    Cardiac failure in β-thalassemia: diagnosis, prevention and management
    • 3
    • PDF
    Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in southern Iran
    • 14
    Cardiac magnetic resonance in transfusion dependent thalassaemia: assessment of iron load and relationship to left ventricular ejection fraction
    • 12
    Cardiac Function and Iron Chelation in Thalassemia Major and Intermedia: a Review of the Underlying Pathophysiology and Approach to Chelation Management
    • 11
    Thalassemia and its relevance to personalized medicine.
    • 2
    The heart in transfusion dependent homozygous thalassaemia today – prediction, prevention and management
    • 66